Beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer - PubMed (original) (raw)
Beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer
K Hovanes et al. Nat Genet. 2001 May.
Abstract
Constitutive activation of the Wnt signaling pathway is a root cause of many colon cancers. Activation of this pathway is caused by genetic mutations that stabilize the beta-catenin protein, allowing it to accumulate in the nucleus and form complexes with any member of the lymphoid enhancer factor (LEF1) and T-cell factor (TCF1, TCF3, TCF4) family of transcription factors (referred to collectively as LEF/TCFs) to activate transcription of target genes. Target genes such as MYC, CCND1, MMP7 and TCF7 (refs. 5-9) are normally expressed in colon tissue, so it has been proposed that abnormal expression levels or patterns imposed by beta-catenin/TCF complexes have a role in tumor progression. We report here that LEF1 is a new type of target gene ectopically activated in colon cancer. The pattern of this ectopic expression is unusual because it derives from selective activation of a promoter for a full-length LEF1 isoform that binds beta-catenin, but not a second, intronic promoter that drives expression of a dominant-negative isoform. beta-catenin/TCF complexes can activate the promoter for full-length LEF1, indicating that in cancer high levels of these complexes misregulate transcription to favor a positive feedback loop for Wnt signaling by inducing selective expression of full-length, beta-catenin-sensitive forms of LEF/TCFs.
Comment in
- LEF1 turns over a new leaf.
de Lau W, Clevers H. de Lau W, et al. Nat Genet. 2001 May;28(1):3-4. doi: 10.1038/ng0501-3. Nat Genet. 2001. PMID: 11326260 No abstract available.
Similar articles
- A new beta-catenin-dependent activation domain in T cell factor.
Atcha FA, Munguia JE, Li TW, Hovanes K, Waterman ML. Atcha FA, et al. J Biol Chem. 2003 May 2;278(18):16169-75. doi: 10.1074/jbc.M213218200. Epub 2003 Feb 11. J Biol Chem. 2003. PMID: 12582159 - Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways.
Labbé E, Letamendia A, Attisano L. Labbé E, et al. Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8358-63. doi: 10.1073/pnas.150152697. Proc Natl Acad Sci U S A. 2000. PMID: 10890911 Free PMC article. - Induction of a beta-catenin-LEF-1 complex by wnt-1 and transforming mutants of beta-catenin.
Porfiri E, Rubinfeld B, Albert I, Hovanes K, Waterman M, Polakis P. Porfiri E, et al. Oncogene. 1997 Dec 4;15(23):2833-9. doi: 10.1038/sj.onc.1201462. Oncogene. 1997. PMID: 9419974 - Lymphoid enhancer factor/T cell factor expression in colorectal cancer.
Waterman ML. Waterman ML. Cancer Metastasis Rev. 2004 Jan-Jun;23(1-2):41-52. doi: 10.1023/a:1025858928620. Cancer Metastasis Rev. 2004. PMID: 15000148 Review. - The Yin-Yang of TCF/beta-catenin signaling.
Barker N, Morin PJ, Clevers H. Barker N, et al. Adv Cancer Res. 2000;77:1-24. doi: 10.1016/s0065-230x(08)60783-6. Adv Cancer Res. 2000. PMID: 10549354 Review.
Cited by
- Integrated enhancer regulatory network by enhancer-promoter looping in gastric cancer.
Zhu T, Okabe A, Usui G, Fujiki R, Komiyama D, Huang KK, Seki M, Fukuyo M, Abe H, Ning M, Okada T, Minami M, Matsumoto M, Fan Q, Rahmutulla B, Hoshii T, Tan P, Morikawa T, Ushiku T, Kaneda A. Zhu T, et al. NAR Cancer. 2024 May 8;6(2):zcae020. doi: 10.1093/narcan/zcae020. eCollection 2024 Jun. NAR Cancer. 2024. PMID: 38720882 Free PMC article. - PAX1 represses canonical Wnt signaling pathway and plays dual roles during endoderm differentiation.
Miao D, Ren J, Jia Y, Jia Y, Li Y, Huang H, Gao R. Miao D, et al. Cell Commun Signal. 2024 Apr 26;22(1):242. doi: 10.1186/s12964-024-01629-3. Cell Commun Signal. 2024. PMID: 38664733 Free PMC article. - Recurrent UBE3C-LRP5 translocations in head and neck cancer with therapeutic implications.
Dharavath B, Butle A, Chaudhary A, Pal A, Desai S, Chowdhury A, Thorat R, Upadhyay P, Nair S, Dutt A. Dharavath B, et al. NPJ Precis Oncol. 2024 Mar 4;8(1):63. doi: 10.1038/s41698-024-00555-4. NPJ Precis Oncol. 2024. PMID: 38438481 Free PMC article. - A distinct isoform of lymphoid enhancer binding factor 1 (LEF1) epigenetically restricts EBV reactivation to maintain viral latency.
Ward BJH, Prasai K, Schaal DL, Wang J, Scott RS. Ward BJH, et al. PLoS Pathog. 2023 Dec 19;19(12):e1011873. doi: 10.1371/journal.ppat.1011873. eCollection 2023 Dec. PLoS Pathog. 2023. PMID: 38113273 Free PMC article. - Effects of S-Adenosylhomocysteine Hydrolase Downregulation on Wnt Signaling Pathway in SW480 Cells.
Pavičić I, Rokić F, Vugrek O. Pavičić I, et al. Int J Mol Sci. 2023 Nov 8;24(22):16102. doi: 10.3390/ijms242216102. Int J Mol Sci. 2023. PMID: 38003292 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous